Physician profile
Scott R Musick
NPI 1386672392
$102,351.75
in general payments reported to CMS, 2019-2025
30 companies · $6,007 in 2025
The $6,007 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,914 · 2020: $9,003 · 2021: $9,428 · 2022: $27K · 2023: $25K · 2024: $18K · 2025: $6,007.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $40K · Food and Beverage: $3,512 · Consulting Fee: $3,500 · Travel and Lodging: $1,860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $40,256.00 |
| Food and Beverage | $3,511.56 |
| Consulting Fee | $3,500.00 |
| Travel and Lodging | $1,859.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $50,295.13 | 2019-2025 | Repatha, Repatha, Otezla |
| Astrazeneca Pharmaceuticals Lp | $15,809.05 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $11,910.18 | 2021-2025 | |
| Allergan, INC. | $10,461.51 | 2019-2021 | |
| Abbvie INC. | $6,980.94 | 2021-2025 | |
| Exact Sciences Corporation | $3,640.94 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $579.52 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $442.29 | 2019-2025 | Jardiance |
| Dexcom, INC. | $364.65 | 2021-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $289.76 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astellas Pharma US INC | $286.15 | 2019-2025 | Veozah |
| Inari Medical, INC. | $263.59 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Esperion Therapeutics, INC. | $187.17 | 2021 | |
| Amarin Pharma, INC. | $122.10 | 2020 | |
| Clarus Therapeutics INC. | $107.63 | 2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $104.94 | 2022-2025 | Caplyta |
| Lilly USA, LLC | $82.63 | 2022-2025 | Mounjaro |
| Pfizer INC. | $81.93 | 2020-2025 | |
| Vanda Pharmaceuticals INC. | $50.38 | 2025 | Fanapt |
| Merck Sharp & Dohme LLC | $50.38 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Supernus Pharmaceuticals, INC. | $49.31 | 2020-2025 | |
| Corium, LLC | $35.96 | 2025 | Azstarys |
| Sumitomo Pharma America, INC. | $35.76 | 2025 | Gemtesa |
| Lundbeck LLC | $26.99 | 2025 | Rexulti |
| Gilead Sciences, INC. | $20.87 | 2023 | Epclusa |
| Collegium Pharmaceutical, INC. | $18.42 | 2025 | Jornay Pm |
| E.R. Squibb & Sons, L.L.C. | $15.65 | 2023 | Eliquis |
| Idorsia Pharmaceuticals US INC | $14.41 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 | |
| Horizon Therapeutics Plc | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Musick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.